Skip to content

Comparison of ?Effectiveness of Spinal Anesthesia with General Anesthesia during Operative Hysteroscopy

Comparison of Effectiveness of Spinal Anesthesia with Total Intravenous Anesthesia during Operative Hysteroscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201402187013N11
Enrollment
76
Registered
2014-06-06
Start date
2014-05-24
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

External causes of morbidity and mortality. Sequelae of external causes of morbidity and mortality

Interventions

Intervention 1: In the control group (n=38) patients undergoing total intravenous anesthesia with midazolam, remifentanil and propofol. Maintenance of anesthesia is being with infusion of remifentanyl
Treatment - Drugs
In the control group (n=38) patients undergoing total intravenous anesthesia with midazolam, remifentanil and propofol. Maintenance of anesthesia is being with infusion of remifentanyl and propofl dur
In the study group (n=38) patients undergoing spinal anesthesia at patient in sitting position, l3-4 or l4-5 interspinous space with 25-G quinke needle, and lidocaine 50 mg and fentanyl 15 µg medic

Sponsors

Vice Chancellor for Research, Tabriz University of Medical? Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patient aged 20-70 years; ASA class I or II; operative hysteroscopy; immediately after menstruation. Exclusion criteria: contraindication for neuraxial block; allergy to local anesthetics; systemic disorders( cardiac, respiratory, hepatic, ...); psychosomatic disease; diagnostic hysteroscopy; large fibroid ( uterine size> 12 w),and uterine prolapses.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
?mount of irrigation fluid absorbed. Timepoint: End of operation. Method of measurement: ml.;Patient's satisfaction scoring. Timepoint: During 24h after operation. Method of measurement: A four-point scale( weak, moderate, good, and excelent).

Secondary

MeasureTime frame
Serum sodium levels. Timepoint: End of operation. Method of measurement: mEq/l.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Simin Atashkhoyi

Tabriz University of Medical Sciences

satashkhoyi@gmail.com siminatashkhoii@yahoo.com00

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026